] i ) represent an important physiological signal in cells (1) . A rise in smooth muscle cell [Ca 2ϩ ] i activates myosin light chain kinase, which promotes myosin light chain phosphorylation and actomyosin interaction. However, recent evidence has indicated that Ca 2ϩ -dependent signaling cascades are highly compartmentalized, suggesting that a nonspecific global rise in [Ca 2ϩ ] i per se is insufficient to evoke a specific physiological outcome. For example, ionomycininduced rises in global [Ca 2ϩ ] i do not regulate membrane-delimited enzyme function as efficiently as Ca 2ϩ entry across the cell membrane (8, 10, 11, 22) . Similarly, large-scale increases in [Ca 2ϩ ] i do not always increase myosin light chain phosphorylation (13 (30) . Despite the widespread significance of SOC entry, the molecular identity of SOC channels remains unclear (16) . Transient receptor potential (Trp) gene products are the best candidates for SOC entry channels. The Drosophila melanogaster Trp gene was identified in 1989 (reviewed in Ref. 16 ) and was later determined to encode a retinal SOC entry channel. Since 1995, seven related mammalian homologs have been identified, several of which encode for SOC entry channels (at least Trp1, Trp2, Trp4, and Trp5) (16, 36) . Other Trp homologs, most notably Trp3, directly interact with the Ins(1,4,5)P 3 receptor (4, 19, 20) . Although these findings suggest that individual Trp proteins exhibit unique regulatory properties, extrapolation of the findings to endogenously expressed Trp-containing channels is not evident. Functional Trp channels may be formed by cohesion of four distinct subunits that assemble as homo-or heteromultimers (2). The biophysical properties of individual Trp proteins that are overexpressed to presumably form homotetrameric channels differ substantially from the biophysical properties observed when different Trp proteins are overexpressed together and allowed to coassemble (23) . These data suggest that the combination of Trp proteins expressed may partly determine whether the channels are store and/or receptor operated. Thus the expression pattern of Trp proteins may produce cell type-specific channels.
Several agonists have been used to activate SOC entry and to examine Ca 2ϩ entry through Trp chan-nels. Thapsigargin is a plant alkaloid that inhibits sarco(endo)plasmic reticulum Ca 2ϩ -ATPase and causes the passive depletion of endoplasmic reticulum Ca 2ϩ without the confounding influence of G proteins (33) . Studies using thapsigargin and related compounds [e.g., 2,5Ј-di(tert-butyl)-1,4-benzohydroquinone, cyclopiazonic acid] illustrate that smooth muscle cells possess SOC entry pathways. However, a clear link between SOC entry and smooth muscle contraction has not been established (3, 14, 34) , perhaps because thapsigargin stimulates endothelial production of nitric oxide (25) . In vivo G q agonists represent the prominent stimulus for activation of SOC entry. The ␣-adrenoreceptor is such a G q -Ins(1,4,5)P 3 -linked pathway that regulates the contractile status of blood vessels. However, studies to date have not clarified whether ␣-adrenergic agonists induce vasoconstriction through SOC entry channels (3) because G q -linked pathways cause membrane depolarization and can activate voltage-gated Ca 2ϩ channels that are thought to predominate in smooth muscle (5, 7) .
Activation of L-type Ca 2ϩ channels has been clearly linked to pulmonary and systemic vasoconstriction. Membrane depolarization with high K ϩ -containing physiological salt solutions rapidly activates these channels, increasing [Ca 2ϩ ] i solely through Ca 2ϩ entry across the plasmalemma. This effect is not limited to experimental preparations because physiological changes in PO 2 regulate resting membrane potential (32) . Acute hypoxia inhibits voltage-dependent K ϩ channel activity and reversibly depolarizes the resting membrane potential sufficiently to activate Ca 2ϩ entry, resulting in an approximate threefold elevation in [Ca 2ϩ ] i (9, 29, 38) . Consequently, hypoxia may cause vasoconstriction by acting directly on smooth muscle. L-type Ca 2ϩ channels proved to be an effective pharmacological target for the treatment of systemic and, to some extent, pulmonary hypertension. However, in considering the possibility that ␣-adrenoreceptor agonists may increase [Ca 2ϩ ] i through activation of either voltage-gated or store-operated Ca 2ϩ channels, the source of Ca 2ϩ responsible for vasoconstriction remains unclear.
Indeed, it was this very problem that was addressed by McDaniel et al. (24) . They found that although inhibition of the L-type Ca 2ϩ channel abolished vasoconstriction induced by high-K ϩ buffer, nifedipine and verapamil only reduced the phenylephrine-induced contraction by 30%. These findings suggested that either Ca 2ϩ -independent mechanisms were evoked by the G q agonist or that another Ca 2ϩ source was required for phenylephrine to sustain a contraction. Recalcification experiments were performed to address this issue. Phenylephrine was applied in the absence of extracellular Ca 2ϩ to initiate Ins(1,4,5)P 3 -dependent Ca 2ϩ release. Ca 2ϩ was then readded to the extracellular buffer to initiate Ca 2ϩ entry in the presence or absence of ␣-adrenoreceptor and L-type Ca 2ϩ channel blockade. Under these experimental conditions, ϳ30% of the vasoconstriction induced by phenylephrine was attributable to SOC entry.
Efforts to characterize the SOC entry pathway revealed that store depletion increased [Ca 2ϩ ] i in cultured smooth muscle cells and also activated a cationic current in the whole cell voltage-clamp configuration. In patch-clamp experiments, the holding potential was 0 mV to inactivate L-type Ca 2ϩ channels. The cyclopiazonic acid-activated current (I SOC ) was large (approximately Ϫ500 pA at Ϫ80 mV), reversed near 0 mV, was linear (e.g., was not inwardly rectifying), and was inhibited by Ni 2ϩ (1 mM) and La 3ϩ (50 M). These data resemble the nonselective currents observed in response to Ca 2ϩ store depletion in other cell types and do not resemble Ca 2ϩ release-activated Ca 2ϩ current (I CRAC ) found initially in mast cells and lymphocytes. I CRAC is very small (less than approximately Ϫ50 pA at Ϫ80 mV), exhibits a positive reversal potential (approximately ϩ40 mV), and is strongly inwardly rectifying. Highly Ca 2ϩ -selective channels possess an anomalous mole fraction effect where monovalent cations are readily conducted in the absence of Ca 2ϩ but excluded in the presence of low Ca 2ϩ concentrations (15, 17, 21, 37) . In this regard, both I CRAC and voltagegated Ca 2ϩ channels exhibit anomalous mole fraction behavior. The issue of ion selectivity is critical to the development of an overall understanding of the apparent myocyte Ca 2ϩ entry pathway(s) because it is likely that the molecular makeup of Ca 2ϩ -nonselective and -selective store-operated channels is distinct. The findings of McDaniel et al. (24) suggest that at least one smooth muscle cell SOC entry pathway is nonselective, generally consistent with the recent work of Trepakova et al. (35) .
McDaniel et al. (24) report expression of Trp1, -2, -4, -5, and -6 in isolated myocytes. These findings implicate Trp proteins in myocyte I SOC but, at the present time, do not provide direct evidence for which channel or combination of subunits contributes to the observed nonselective current. Ion selectivity of Trp proteins is still largely unresolved. Of the channels examined to date, only Trp4 and Trp5 appear to encode for a Ca 2ϩ -selective channel (26) (27) (28) 37) , and even this finding has been inconsistent (31) . When evaluated, nonselective currents have generally been observed after overexpression of Trp1 (39) (12) . Antisense inhibition of Trp1 reduced this Ca 2ϩ -selective current by 50% and did not left shift the reversal potential from ϩ40 mV. These findings were interpreted to suggest that although Trp1 may form a structural subunit of a Ca 2ϩ -selective store-operated channel, it is likely not required to establish the Ca 2ϩ selectivity of the channel. Thus although it is evident that cation entry occurs through Trp proteins in response to Ca 2ϩ store depletion, the endogenous makeup of these channels and their contribution(s) to nonselective cation and/or Ca 2ϩ -selective currents are unclear. Overall, the findings presented by McDaniel et al. (24) address an important question and underscore L867 how little is known regarding the fundamental aspects of Ca 2ϩ signaling in the control of vasoconstriction. As we continue to resolve the detail of signal transduction pathways, it will be critical to establish more specifically which Trp proteins coalesce to form functional channels and to determine how these channels generate nonselective versus Ca 2ϩ -selective currents. It will be equally important to discern how SOC entry pathways work in combination with L-type Ca 2ϩ channels to uniformly or discretely regulate vascular tone. Resolution of these issues may result in the generation of novel antihypertensive pharmacotherapeutic agents directed against myocyte-specific, Trp-containing SOC entry channels.
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